(Q37787414)

English

Multi-Institutional Phase II Study of Proton Beam Therapy for Organ-Confined Prostate Cancer Focusing on the Incidence of Late Rectal Toxicities

scientific article published on 09 September 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Multi-Institutional Phase II Study of Proton Beam Therapy for Organ-Confined Prostate Cancer Focusing on the Incidence of Late Rectal Toxicities (English)

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Keiji Nihei

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Takashi Ogino

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Masakatsu Onozawa

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Shigeyuki Murayama

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Hiroshi Fuji

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Masao Murakami

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Yoshio Hishikawa

7

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

9 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0360301610007509?httpAccept=text/xml

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

https://api.elsevier.com/content/article/PII:S0360301610007509?httpAccept=text/plain

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

390-396

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Irradiation of carcinoma of the prostate localized to the pelvis: analysis of tumor response and prognosis

1

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

The effect of dose on local control of prostate cancer

2

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

3

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06

4

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States

5

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study

6

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Intensity-modulated radiation therapy: supportive data for prostate cancer

7

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

8

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

9

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

10

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

11

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

12

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

13

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

14

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II

15

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

16

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan

17

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406

18

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant

19

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control

20

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer

21

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Conformal proton therapy for prostate carcinoma

22

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

24

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions

25

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

What hypofractionated protocols should be tested for prostate cancer?

26

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes

27

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

28

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer

29

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.

30

1 reference

10.1016/J.IJROBP.2010.05.027

https://api.crossref.org/works/10.1016/J.IJROBP.2010.05.027

10 July 2024

Identifiers

10.1016/J.IJROBP.2010.05.027

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37787414&oldid=2228296875"